| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.68B | +62.8% |
| Cost of Revenue | $346.7M | +48.0% |
| Gross Profit | $1.33B | +67.2% |
| R&D Expense | $752.4M | +79.2% |
| SG&A Expense | $139.4M | +47.6% |
| Operating Income | -$58.7M | -206.4% |
| Interest Expense | $16.5M | -21.5% |
| Pre-tax Income | -$38.1M | -106.7% |
| Income Tax | $12.1M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $339.0M | +25.1% |
| Accounts Receivable | $399.6M | +48.6% |
| Current Assets | $2.34B | +25.3% |
| Total Assets | $3.00B | +26.2% |
| Current Liabilities | $759.7M | +43.7% |
| Total Liabilities | $1.59B | +19.0% |
| Stockholders' Equity | $1.41B | +35.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $418.4M | +46.0% |
| Capital Expenditures | $35.3M | +254.2% |
| Investing Cash Flow | -$384.7M | -40.5% |
| Financing Cash Flow | $36.0M | +3.1% |
| Free Cash Flow | $383.1M | +38.5% |
| +420.4% |
| Net Income | -$50.2M | -141.8% |
| EPS (Basic) | -$0.16 | -128.6% |
| EPS (Diluted) | -$0.16 | -128.6% |